Grown Rogue International (GRUSF) Short term Debt (2009 - 2025)
Grown Rogue International's (GRUSF) quarterly Short term Debt came in at $1.7 million in Q1 2025, down 100.0% quarter-over-quarter from $1945.2 billion in Q4 2024.
Grown Rogue International (GRUSF) Short term Debt (2009 - 2025) Analysis & Trends
Grown Rogue International's Short term Debt history runs 15 years deep, the most recent figure standing at $1.7 million for Q1 2025.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $1.7 million in Q1 2025; TTM through Mar 2025 was $1.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1945.2 billion, up 249273438.56% from the prior year.
- Short term Debt retreated to $1.7 million in Q1 2025 per GRUSF's latest filing, from $1945.2 billion in the prior quarter.
- Across five years, Short term Debt topped out at $1945.2 billion in Q4 2024 and bottomed at $194426.0 in Q1 2023.
- The 5-year median for Short term Debt is $1.1 million (2021), against an average of $243.2 billion.
- Across the five-year window, Short term Debt slipped 27.35% in 2023 and jumped 249273438.56% in 2024, its largest moves.
- Year by year, Short term Debt stood at $843900.0 in 2021, then soared by 109.69% to $1.8 million in 2022, then slumped by 55.9% to $780358.0 in 2023, then soared by 249273438.56% to $1945.2 billion in 2024, then sank by 100.0% to $1.7 million in 2025.
- Per Business Quant, the three latest GRUSF Short term Debt figures stand at $1.7 million (Q1 2025), $1945.2 billion (Q4 2024), and $780358.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1,945.23 Bn |
| Dec 31, 2023 | 780,358.00 |
| Oct 31, 2023 | 1.29 Mn |
| Apr 30, 2023 | 209,133.00 |
| Jan 31, 2023 | 194,426.00 |
| Oct 31, 2022 | 1.77 Mn |
| Oct 31, 2021 | 843,900.00 |
| Oct 31, 2020 | 46,099.00 |
| Oct 31, 2019 | 150,000.00 |
| Aug 31, 2018 | 37,741.19 |
| May 31, 2018 | 58,173.47 |
| Feb 28, 2018 | 52,325.74 |
| Nov 30, 2017 | 27,902.43 |
| May 31, 2017 | 131,167.75 |
| Feb 28, 2017 | 37,678.18 |
| Nov 30, 2015 | -91,670.79 |
| Aug 31, 2015 | -218,624.66 |
| May 31, 2015 | 151,781.21 |
| Feb 28, 2015 | -100,962.33 |